Bekzod Rozibaev is a medical student at Tashkent State Medical University, where he began his studies in 2021. His academic interests are strongly oriented toward cardiology and related disciplines, with particular attention to arterial hypertension, atrial fibrillation, and cardiomyopathies. He is also engaged in the study of genetic determinants of cardiovascular disease, focusing on polymorphisms that may influence disease progression, risk stratification, and individualized therapy in the Uzbek population. In addition to core cardiology, Bekzod participates in interdisciplinary projects that explore innovative approaches to prevention and treatment. He is currently involved in research on the effectiveness of artificial intelligence–guided diets compared with the traditional Mediterranean diet, examining their impact on cardiovascular health, metabolic parameters, and long-term outcomes.